» Articles » PMID: 26367223

Continuous IV Infusion of MESNA Can Prevent Hemorrhagic Cystitis in HSCT and Retain MESNA Concentration in Urine

Overview
Specialty General Surgery
Date 2015 Sep 15
PMID 26367223
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

Role of Natural Antioxidants in Cancer.

Alsulami F, Shaheed S Cancer Treat Res. 2024; 191:95-117.

PMID: 39133405 DOI: 10.1007/978-3-031-55622-7_4.


Canadian Urological Association Best Practice Report: Pediatric hemorrhagic cystitis.

Hannick J, Koyle M Can Urol Assoc J. 2019; 13(11):E325-E334.

PMID: 31763977 PMC: 6877374. DOI: 10.5489/cuaj.5993.

References
1.
Haselberger M, Schwinghammer T . Efficacy of mesna for prevention of hemorrhagic cystitis after high-dose cyclophosphamide therapy. Ann Pharmacother. 1995; 29(9):918-21. DOI: 10.1177/106002809502900914. View

2.
Takamoto S, Sakura N, Yashiki M, Kojima T . Inactivation of acrolein by sodium 2-mercaptoethanesulfonate using headspace-solid-phase microextraction gas chromatography and mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 791(1-2):365-9. DOI: 10.1016/s1570-0232(03)00259-9. View

3.
Lima M, Ferreira F, Macedo F, Brito G, Ribeiro R . Histological changes in bladders of patients submitted to ifosfamide chemotherapy even with mesna prophylaxis. Cancer Chemother Pharmacol. 2006; 59(5):643-50. DOI: 10.1007/s00280-006-0307-5. View

4.
Giraud G, Bogdanovic G, Priftakis P, Remberger M, Svahn B, Barkholt L . The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica. 2006; 91(3):401-4. View

5.
Korkmaz A, Topal T, Oter S . Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol. 2007; 23(5):303-12. DOI: 10.1007/s10565-006-0078-0. View